Regeneron plots 400 hires to handle increased workload amid COVID-19 cocktail production push
Earlier this month, Regeneron and Roche made a manufacturing pact to triple production of a COVID-19 antibody cocktail. Those plans have made it difficult for Regeneron to churn out its regular meds, so it’s expanding to keep up.
Regeneron will add up to 400 jobs at its Limerick, Ireland, manufacturing facility to handle its increased workload. The new hires will mostly be specialists on the manufacturing side and bring Regeneron’s total workforce at the site to more than 1,400.
